biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs

Bullboard Posts

Comment by Sinbobon Apr 04, 2013 6:56pm

139 Views

Post# 21213103

RE: RE: RE: RE: RE: 'peripheral' considerations

I also apologized to you, have given you kudos at times for certain posts and yes, it is a two way street and I could again defend myself by going into repasting some of your posts that were less than kind too. I have also admitted that I was wrong at times. So, I realize JD and you are friends that protect each other and this will lead nowhere. The standards work both ways and all is available on record for those who care for the trivia trail on us. I the end, it is wasting others time.

Bullboard Posts

Rig Count Soars as Utilization Surpasses Industry Averages